Most bought healthcare stocks in Q2 2015
See which Healthcare stocks institutional investors increased the most in Q2 2015, measured as net growth in reported share positions from Q1 2015 into Q2 2015. Notable additions at the top of this list include WALGREENS BOOTS ALLIANCE INC (WBA), DANAHER CORP (DHR), SANOFI-ADR (SNY), MERCK & CO. INC. (MRK). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC | 12,970,149 | $1.09B | 0 | 3 | 5 | 0 | 10 |
| DHR | DANAHER CORP | 8,002,869 | $698.75M | 2 | 1 | 3 | 0 | 7 |
| SNY | SANOFI-ADR | 6,692,219 | $336.10M | 0 | 2 | 2 | 0 | 7 |
| MRK | MERCK & CO. INC. | 3,504,743 | $183.79M | 1 | 3 | 5 | 1 | 12 |
| BAX | BAXTER INTERNATIONAL INC | 2,576,841 | $197.86M | 2 | 2 | 5 | 1 | 10 |
| BDX | BECTON DICKINSON AND CO | 2,248,145 | $307.51M | 1 | 5 | 4 | 0 | 11 |
| HUM | HUMANA INC | 1,596,177 | $327.76M | 1 | 1 | 1 | 1 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | 1,258,188 | $101.39M | 0 | 1 | 0 | 0 | 1 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 1,091,743 | $159.28M | 1 | 0 | 1 | 1 | 2 |
| COR | CENCORA INC | 1,085,300 | $115.41M | 1 | 0 | 0 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 780,200 | $34.75M | 0 | 1 | 0 | 0 | 2 |
| ARAY | ACCURAY INC | 682,952 | $3.46M | 0 | 1 | 0 | 0 | 1 |
| OPK | OPKO HEALTH INC | 654,100 | $12.91M | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 646,214 | $3.91M | 1 | 1 | 0 | 0 | 2 |
| MCK | MCKESSON CORP | 559,014 | $124.80M | 3 | 0 | 0 | 1 | 3 |
| CNC | CENTENE CORP | 552,300 | $49.41M | 0 | 1 | 0 | 0 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | 541,400 | $1.92M | 0 | 1 | 0 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | 454,700 | $34.10M | 0 | 1 | 0 | 0 | 1 |
| UTHR | UNITED THERAPEUTICS CORP | 419,378 | $74.19M | 0 | 2 | 0 | 0 | 2 |
| BIIB | BIOGEN INC | 413,358 | $163.04M | 1 | 1 | 2 | 1 | 4 |
| MDXG | MIMEDX GROUP INC | 407,100 | $4.93M | 0 | 1 | 0 | 0 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | 381,239 | $3.92M | 1 | 0 | 0 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 358,500 | $15.13M | 0 | 2 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 275,000 | $28.66M | 1 | 0 | 0 | 0 | 1 |
| PRGO | Perrigo Company PLC | 274,055 | $131.81M | 2 | 1 | 3 | 0 | 6 |
| OMI | OWENS & MINOR INC | 222,425 | $7.76M | 0 | 2 | 0 | 0 | 2 |
| AMPH | AMPHASTAR PHARMACEUTICALS IN | 193,626 | $3.73M | 0 | 1 | 0 | 0 | 1 |
| CDXS | CODEXIS INC | 192,300 | $439.00K | 0 | 1 | 0 | 0 | 1 |
| CTLT | CATALENT INC | 191,261 | $5.61M | 1 | 0 | 0 | 0 | 1 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 184,300 | $1.05M | 0 | 1 | 0 | 0 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | 183,177 | $23.44M | 0 | 2 | 0 | 0 | 2 |
| CRL | CHARLES RIVER LABORATORIES | 174,482 | -$10.89M | 0 | 1 | 1 | 0 | 2 |
| LXRX | LEXICON PHARMACEUTICALS INC | 170,153 | $1.37M | 1 | 0 | 0 | 0 | 1 |
| RDY | DR. REDDY'S LABORATORIES-ADR | 169,600 | $8.57M | 0 | 2 | 0 | 0 | 2 |
| MMSI | MERIT MEDICAL SYSTEMS INC | 158,214 | $4.02M | 0 | 1 | 0 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 157,900 | $5.76M | 0 | 1 | 0 | 0 | 2 |
| ICAD | ICAD INC | 146,982 | -$1.46M | 0 | 1 | 0 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | 125,700 | $3.75M | 0 | 1 | 0 | 0 | 1 |
| NVRO | NEVRO CORP | 119,600 | $6.43M | 1 | 0 | 0 | 0 | 1 |
| CUTR | CUTERA INC | 115,470 | $3.87M | 0 | 1 | 0 | 0 | 1 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 115,000 | $1.95M | 1 | 0 | 0 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 104,750 | $37.35M | 0 | 1 | 1 | 0 | 2 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 102,399 | $12.31M | 1 | 0 | 0 | 0 | 2 |
| HSTM | HEALTHSTREAM INC | 100,469 | $3.75M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 97,411 | $16.44M | 1 | 0 | 1 | 0 | 2 |
| LGND | LIGAND PHARMACEUTICALS | 96,094 | $9.70M | 1 | 0 | 0 | 0 | 1 |
| NEO | NEOGENOMICS INC | 93,500 | $687.00K | 0 | 1 | 0 | 0 | 1 |
| HQY | HEALTHEQUITY INC | 91,900 | $3.85M | 0 | 1 | 0 | 0 | 2 |
| RGEN | REPLIGEN CORP | 89,939 | $13.10M | 0 | 1 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 88,800 | $3.45M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2015
What are the most bought Healthcare stocks in Q2 2015?
The most bought healthcare stocks in Q2 2015 are those with the largest increase in reported share counts across institutional investors compared to Q1 2015, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2015?
Among filers in this sector, net additions were largest in companies such as WALGREENS BOOTS ALLIANCE INC (WBA), DANAHER CORP (DHR), SANOFI-ADR (SNY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2015).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.